Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IST: The Big Bang Theory of Device Innovation

Executive Summary

Assembling a Dream Team of surgeons, including those of The Texas Back Institute, as well as leading medical device companies, IST sought to create an incubator in spine unparalleled in its ability to bring new technology to market. The only thing is, the model didn't work. Now, IST has shifted gears and is pursuing a mega-roll up strategy.

You may also be interested in...



IST Finds a New Model and Some Investors

The Texas Back Institute's incubator, Innovative Spinal Technologies Inc. (IST), has scrapped its first technology transfer model. Last year it , began working with large VCs to re-draw its model and recapitalize the company.

IST Finds a New Model and Some Investors

The Texas Back Institute's incubator, Innovative Spinal Technologies Inc. (IST), has scrapped its first technology transfer model. Last year it , began working with large VCs to re-draw its model and recapitalize the company.

Orthopedic Seed Funding in the City

In May 2005, a leading orthopedics hospital, two health-care focused venture capital firms, a real estate investment trust, and a local economic development group came together to form New York Orthopedic Technologies LLC, in order to fill a gap in seed stage investing in orthopedics. The consortium hopes to address several challenges unique to early stage value creation in medical technology: how to bring particular sets of resources to the entrepreneur or physician with a concept-clinical, financial, operational, and logistical; how to get the technology to the next milestone without creating a model that itself requires care and feeding; and how to create a structure that serves the divergent goals of all the participants.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV002545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel